Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
- Structural Heart Abnormality
- Valve Heart Disease
- Heart Diseases
- Cardiovascular Diseases
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Pierre Elias
- Enrolment target
- 4,000
- Started
- 16 September 2026
- Main results due
- 1 June 2027
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Aged 40 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * 40 years of age or older * Received an ECG upon presentation to the Emergency Department Exclusion Criteria: * Had an echocardiogram within the prior 2 years. * Has a history of structural heart disease. * Not able to receive follow-up based on Community Tele-Paramedicine care manager review. * Quality of life will not improve over the next five years.
What this study is about
In the sponsor’s own words, from the registry.
Doctors are testing a new tool called EchoNext to see if it can help find heart problems earlier. EchoNext looks at the heart's electrical test, called an ECG, and uses artificial intelligence (AI) to check for signs of structural heart disease (SHD). SHD includes conditions like weak heart pumping, heart valve problems, or extra thickening of the heart muscle. These problems are common but often go undiagnosed until they cause serious issues like heart failure or stroke.
The main questions this study will answer are:
Can EchoNext alerts help emergency doctors find hidden heart problems sooner?
Does this lead to more follow-up heart tests, like an echocardiogram (heart ultrasound)?
What this means for patients: If a person has an ECG in the Emergency Department, the EchoNext tool may be used to check their heart. If the tool finds something unusual, their doctor may receive an alert and may then recommend further heart tests or follow-up care.
This study will help researchers learn if using EchoNext improves early diagnosis and treatment of heart disease.
Study sites(1)
Columbia University Irving Medical Center / NewYork-Presbyterian
New York, New York, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07843004. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me